Adenosine Monophosphate Deaminase 1 (AMPD1) (N-Term) Peptide
AMPD1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all AMPD1 products
- AMPD1 (Adenosine Monophosphate Deaminase 1 (AMPD1))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QKSFQRFPKT PSKYLRNIDG EAWVANESFY PVFTPPVKKG EDPFRTDNLP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AMPD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AMPD1 (Adenosine Monophosphate Deaminase 1 (AMPD1))
- Background
-
Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.
Alias Symbols: AMPD1,
Protein Size: 776 - Gene ID
- 270
- NCBI Accession
- NP_001166097
-
You are here:
